CVS Health Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 increased by 5.9% to $2.71B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 11.5%, from $3.06B to $2.71B.
Reflects the company's long-term capital preservation strategy and duration matching for distant liabilities.
This metric measures the fair value of debt securities in the available-for-sale portfolio with maturities exceeding ten...
Standard maturity profile disclosure for utilities with structured investment portfolios.
other_available_for_sale_securities_debt_maturities_afte_b0420b| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.78B | $4.86B | $4.52B | $4.02B | $3.73B | $3.96B | $3.90B | $3.52B | $3.70B | $3.31B | $3.06B | $2.71B | $2.56B | $2.71B |
| QoQ Change | — | +1.6% | -7.0% | -10.9% | -7.2% | +6.1% | -1.4% | -9.9% | +5.3% | -10.6% | -7.4% | -11.6% | -5.5% | +5.9% |
| YoY Change | — | — | — | -15.8% | -23.1% | -12.3% | -2.9% | -5.8% | -6.5% | -15.2% | -12.9% | -26.8% | -22.6% | -11.5% |